PPM ACCESS
Access to the PPM Journal and newsletters is FREE for clinicians.

Meeting Highlights from American Pain Society 31st Annual Scientific Meeting

Meeting Information

May 16-19, 2012
Honolulu, HI

Honolulu, Hawaii, was the site of this year's Annual Scientific Meeting of the American Pain Society (APS)—their 31st. The conference was a gathering of physicians, nurses, basic scientists, pharmacists, psychologists, and other healthcare professionals that make up the multidisciplinary pain team. More than 400 posters were presented, as well as three days of plenary lectures and break-out sessions. Practical Pain Management presents highlights here of a few of the presentations and posters.

From this Meeting:

Read about chronic pain research presented at the 2012 APS Annual Meeting on what prevents people from seeking medical care for their pain.
A novel liquid formulation of capsaicin, NGX-1998 containing 10% and 20% capsaicin, may provide a convenient option for the management of postherpetic neuralgia. Research presented at the 2012 APS Annual Meeting.
Patients with cervical or lumbar herniated disc pain may benefit from intradiscal pressurized injection therapy, according to researchers at the Tokyo Women’s Medical University Hospital in Japan. Learn more in this research highlight article from the APS 2012 Annual Meeting.
Research presented at the 2012 APS Annual Meeting highlights the vitamin D level associated with increased osteoarthritis symptoms. Learn what it is, as well as other results from this chronic pain study.
Prescribed exercise helps patients get moving faster following total knee replacement, while poor pain control and older age hamper recovery: New research presented at the 2012 APS Annual Meeting.
Patients who suffer acute spinal cord injuries (SCIs) are often treated with opioids, which can cause significant bladder and bowel dysfunction. How can this be addressed? Learn in this research summary from the 2012 APS Annual Meeting.
There is growing interest in the use of immunomodulators for the treatment of complex regional pain syndrome (CRPS). Learn more about this pain research presented at the APS 2012 Annual Meeting.
Once-daily gastroretentive formulation of gabapentin (Gralise) has been shown to improve pain and quality of life for patients with postherpetic neuralgia—with pain relief occurring as early as the second day of dosing, according to two poster presentations from the 2012 APS Annual Meeting.
Summary of paper presented at the 2012 APS Annual Meeting. Discusses how best to prevent migraines and who’s at risk of developing migraines.
Research presented at the 2012 American Pain Society meeting on how the brain can be “rewired” to relieve chronic pain. How far away is this pain treatment?
close X
SHOW MAIN MENU
SHOW SUB MENU